University of Turin (UNITO) investigators, partners on the Makerere University Infectious Diseases Institute (IDI)-led consortium CAPA-CT II, are the first to openly publish a method for quantifying remdesivir in blood. Remdesivir has recently received authorisation for emergency use in the US and European Union for patients with severe forms of COVID-19.